IsisCB Explore

Article ID: CBB004387597

Disentangling war and disease in post-conflict Colombia beyond technoscientific peacemaking (2019)

Tapuya: Latin American Science, Technology and Society
Volume: 2
Issue: 1
Pages: 94-111
Publication date: 2019
Language: English

URI: https://doi.org/10.1080/25729861.2018.1532779

DOI: 10.1080/25729861.2018.1532779

Outside Links

WorldCat

Google Scholar

JSTOR

Latin America Pharmaceutical industry Science and technology studies (STS) Peace War and Society Temporality Disease and diseases 21st century

In November 2016, the Colombian government and the Revolutionary Armed Forces of Colombia (FARC) signed a peace agreement to end a 52-year war. In the context of the peace deal implementation, I ethnographically traced entanglements of biomedicine, public health and the armed conflict across shifting temporalities and realities of war and peace. Through an exploration of past, present and future (dis)entanglements of war and leishmaniasis – a vector-borne disease known by many in Colombia as “the subversive disease” or the “guerrilla disease” – this article traces a discourse that frames health problems, like leishmaniasis, only as scientific or technological challenges. Drawing on STS critiques of future-oriented timelines in technoscience and the concept of pharmaceuticalization, I argue that the expectations embedded in technoscientific innovation problematically limit the possibilities of disentangling leishmaniasis and war in post-conflict Colombia. In contrast, ethnographically exploring how health policies and biomedicine have nurtured violence and exclusion helps us destabilize the warfare-loaded meaning and experience of leishmaniasis. This approach enables us to move beyond imaginaries of technoscientific peacemaking, which I define as the excessive trust endowed to technoscience to (re)build a peaceful future, especially when we are faced with failures in understanding the involvement of technoscience in the production and perpetuation of violence.

...More

Associated with

Article Marisa G. Ruiz-Trejo; Dau García-Dauder (2019) Epistemic-corporeal workshops: Putting strong reflexivity into practice. Tapuya: Latin American Science, Technology and Society (pp. 42-58). unapi

Citation URI

data.isiscb.org/p/isis/citation/CBB004387597

This citation is part of the Isis database.

Citations Indexes

Similar Citations

Article Tousignant, Noemi; (October 2013)
Broken tempos: Of means and memory in a Senegalese university laboratory (/p/isis/citation/CBB036851501/)

Essay Review Filip Vostal; (2019)
Acceleration Approximating Science and Technology Studies: On Judy Wajcman’s Recent Oeuvre (/p/isis/citation/CBB255746906/)

Article Caroline White-Nockleby; (2022)
Grid-scale batteries and the politics of storage (/p/isis/citation/CBB962097904/)

Article José David Gómez-Urrego; (2019)
The intersections between infrastructures and expectations: Repair and breakdown in Yachay, the city of knowledge in Ecuador (/p/isis/citation/CBB172370519/)

Article Morten Sager; Teun Zuiderent-Jerak; (May 2021)
Knowing Times: Temporalities of Evidence for Implantable Cardioverter Defibrillators (/p/isis/citation/CBB852337010/)

Article Ildikó Zonga Plájás; (2023)
Permanent Temporality: Race, Time, and the Materiality of Romanian Identity Cards (/p/isis/citation/CBB163106535/)

Article Lynne Pearce; (March 2020)
“Text-as-Means” versus “Text-as-End-in-Itself”: Some Reasons Why Literary Scholars Have Been Slow to Hop on the Mobilities Bus (/p/isis/citation/CBB550769708/)

Article Sandra Harding; Tania Pérez-Bustos; Manuela Fernández-Pinto; (2019)
Entangled sciences of gender, sexuality and race: Latin American issues (/p/isis/citation/CBB649173976/)

Article Sarah Wadmann; Amalie Martinus Hauge; (August 2021)
Strategies of stratification: Regulating market access in the era of personalized medicine (/p/isis/citation/CBB940730003/)

Article Jill A. Fisher; (March 2015)
Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials (/p/isis/citation/CBB066653855/)

Article Judy Z Segal; (August 2018)
Sex, drugs, and rhetoric: The case of flibanserin for ‘female sexual dysfunction’ (/p/isis/citation/CBB311917478/)

Article Margaret E. MacDonald; (March 2021)
Misoprostol: The Social Life of a Life-saving Drug in Global Maternal Health (/p/isis/citation/CBB680292467/)

Article Andrea M. Bertotti; Skye A. Miner; (April 2019)
Constructing contentious and noncontentious facts: How gynecology textbooks create certainty around pharma-contraceptive safety: Research Note (/p/isis/citation/CBB188878802/)

Article Alejandro Barragán-Ocaña; Rubén Oliver-Espinoza; María del Pilar Longar-Blanco; Hortensia Gómez-Viquez; (2022)
Technological development and patent analysis: The case of biopharmacy in the world and in Latin America (/p/isis/citation/CBB871494105/)

Article Natassia F. Brenman; Richard Milne; (May 2022)
“Ready for What?”: Timing and Speculation in Alzheimer’s Disease Drug Development (/p/isis/citation/CBB016946522/)

Book Maki Umemura; (2011)
The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges (/p/isis/citation/CBB223408454/)

Article Javier Lezaun; Catherine M. Montgomery; (2015)
The Pharmaceutical Commons Sharing and Exclusion in Global Health Drug Development (/p/isis/citation/CBB301150395/)

Article Javier Lezaun; Catherine Montgomery; (January 2015)
The Pharmaceutical Commons: Sharing and Exclusion in Global Health Drug Development (/p/isis/citation/CBB051732021/)

Article María González-Moreno; Cristian Saborido; David Teira; (2015)
Disease-mongering through clinical trials (/p/isis/citation/CBB362630000/)

Article Daisuke Konagaya; (April 2021)
How an Imperial Military Laboratory Became a Museum for Peace (/p/isis/citation/CBB646150440/)